Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Congratulations to Dr Beth Psaila, who has won a prestigious Fellowship at the L’Oréal-UNESCO UK and Ireland For Women In Science awards. She was one of five scientists to receive the highly competitive award.

Bethan PsailaThe annual Fellowships programme provides £15,000 of flexible financial support for outstanding female postdoctoral researchers to continue research in their fields, as part of a wider L’Oréal-UNESCO programme aimed at supporting and increasing the number of women working in STEM professions in the UK, where 85% of jobs are held by men.

Dr Beth Psaila (WIMM-NDCLS) is a haematologist examining the role of blood cells in the bone marrow, known as megakaryocytes, in a rare but fatal disease called Myelofibrosis which destroys the bone marrow. Most patients live for fewer than five years after diagnosis, and 20% develop blood cancer. Current treatments help symptoms but do not cure the condition or improve survival. The condition is triggered by a mutation in a key gene called JAK2, and better understanding how the disease develops at a genetic level could help in the design of new treatments.

Dr Steve Shiel, Scientific Director at L’Oréal UK & Ireland, said: “Now in its tenth year, the L’Oréal-UNESCO For Women in Science programme remains as important as ever. Women still face significant barriers to STEM careers, from a shortage of female role models for young children to a lack of support once on their chosen career path. Science needs women, and as a company founded on science, we are committed to ensuring more women are able to enjoy long and successful careers in science.”

Professor Dame Carol Robinson, Head of the Judging Panel and a L'Oréal-UNESCO For Women in Science International Laureate, said: “These awards are well known in the science community and are always fiercely contested because of the vital support they provide. Each of our finalists is working on innovative and ground-breaking research, so selecting the winners was a tough task for the judges, but we are delighted they can now benefit from this support at a crucial stage in their careers, and we look forward to seeing the fruits of their research in the future.”

Similar stories

DNA breakthrough could help identify why some people are more affected by Covid-19

Scientists from the MRC Weatherall Institute of Molecular Medicine have developed a method that allows them to see, with far greater accuracy, how DNA forms large scale structures within a cell nucleus.

New clinical trial for patients affected by blood cancer

Radcliffe Department of Medicine's Professor Adam Mead is leading PROMise, a new clinical trial offering a novel treatment option for patients with a type of blood cancer called myelofibrosis.

Immune cells imperfect at distinguishing friend from foe

When it comes to distinguishing a healthy cell from an infected one that needs to be destroyed, the immune system’s killer T cells sometimes make mistakes. This discovery, described today in the journal eLife, upends a long-held belief among scientists that T cells were nearly perfect at discriminating friend from foe. The results may point to new ways to treat autoimmune diseases that cause the immune system to attack the body, or lead to improvements in cutting-edge cancer treatments.

Professor Graham Ogg elected Academy of Medical Sciences Fellow

Fellows are selected for their exceptional contributions to the advancement of medical science through innovative research discoveries and translating scientific developments into benefits for patients and the wider society.

New funding for early diagnosis research using platelets

Dr Bethan Psaila and her team will investigate the potential of circulating blood platelets for early detection of a range of cancer types.